Thomas D. Hart

633 total citations
13 papers, 361 citations indexed

About

Thomas D. Hart is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Thomas D. Hart has authored 13 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Thomas D. Hart's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Bioinformatics and Genomic Networks (4 papers). Thomas D. Hart is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Bioinformatics and Genomic Networks (4 papers). Thomas D. Hart collaborates with scholars based in United States, Canada and Netherlands. Thomas D. Hart's co-authors include Lei Xie, Yvonne M. Saenger, Robyn D. Gartrell, Falguni Parikh, Jared M. Newton, Andrew G. Sikora, Damya Laoui, Jo A. Van Ginderachter, Hsuan‐Chen Liu and Douglas K. Marks and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Cancer Research.

In The Last Decade

Thomas D. Hart

12 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas D. Hart United States	10	180	171	105	57	43	13	361
Hung Kam Cheung United States	8	224 1.2×	248 1.5×	101 1.0×	47 0.8×	58 1.3×	11	466
Shahin Assefnia United States	6	112 0.6×	178 1.0×	57 0.5×	66 1.2×	13 0.3×	7	313
Itziar Irurzun‐Arana Spain	10	173 1.0×	210 1.2×	46 0.4×	37 0.6×	59 1.4×	17	364
Sofía Bruni Argentina	7	193 1.1×	130 0.8×	131 1.2×	13 0.2×	41 1.0×	13	383
Meghan M. Joly United States	10	72 0.4×	222 1.3×	28 0.3×	21 0.4×	30 0.7×	14	337
Akito Nakamura Japan	8	119 0.7×	326 1.9×	42 0.4×	60 1.1×	31 0.7×	13	424
Gizem Gülfidan Türkiye	12	71 0.4×	244 1.4×	29 0.3×	47 0.8×	83 1.9×	23	397
Yung-Chieh Chang Taiwan	10	137 0.8×	343 2.0×	55 0.5×	13 0.2×	52 1.2×	15	520
Frank Grollman United States	6	166 0.9×	256 1.5×	58 0.6×	23 0.4×	49 1.1×	12	390
Saketh S. Dinavahi United States	11	136 0.8×	222 1.3×	82 0.8×	15 0.3×	42 1.0×	17	409

Countries citing papers authored by Thomas D. Hart

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Hart more than expected).

Fields of papers citing papers by Thomas D. Hart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Hart. The network helps show where Thomas D. Hart may publish in the future.

Co-authorship network of co-authors of Thomas D. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Hart. A scholar is included among the top collaborators of Thomas D. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Hart. Thomas D. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hart, Thomas D., et al.. (2021). Isolated headache is not a reliable indicator for brain cancer: the 2-week wait pathway for suspected CNS malignancies. Clinical Medicine. 21(6). e648–e655.

Gartrell, Robyn D., Andrew Chen, Emanuelle M. Rizk, et al.. (2020). Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma. Cancer Research. 80(5). 1078–1087. 17 indexed citations

Marks, Douglas K., Robyn D. Gartrell, Margueritta El Asmar, et al.. (2020). Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer. Frontiers in Oncology. 10. 968–968. 20 indexed citations

Newton, Jared M., Hsuan‐Chen Liu, Falguni Parikh, et al.. (2019). Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition. Journal for ImmunoTherapy of Cancer. 7(1). 216–216. 63 indexed citations

Newton, Jared M., Rosemarie Krupar, Chen Huang, et al.. (2019). Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 10–10. 68 indexed citations

Blake, Zoë, Douglas K. Marks, Robyn D. Gartrell, et al.. (2018). Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition. Journal for ImmunoTherapy of Cancer. 6(1). 25–25. 29 indexed citations

Komatsubara, Kimberly M., Robyn D. Gartrell, Thomas D. Hart, et al.. (2018). Characterization and spatial localization of the tumor immune microenvironment in metastatic uveal melanoma.. Journal of Clinical Oncology. 36(15_suppl). 9570–9570. 2 indexed citations

Lopez, Adriana T., Robyn D. Gartrell, Kimberly M. Komatsubara, et al.. (2018). The Role of Oncolytic Viruses in the Treatment of Melanoma. Current Oncology Reports. 20(10). 80–80. 37 indexed citations

Gartrell, Robyn D., Kimberly M. Komatsubara, Douglas K. Marks, et al.. (2018). Quantitative multiplex immunofluorescence to identify candidate biomarkers of response to anti-PD1 in metastatic melanoma.. Journal of Clinical Oncology. 36(15_suppl). e21600–e21600. 1 indexed citations

10.

Hart, Thomas D., et al.. (2016). Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology. Scientific Reports. 6(1). 20441–20441. 37 indexed citations

11.

Hart, Thomas D. & Lei Xie. (2015). Providing data science support for systems pharmacology and its implications to drug discovery. Expert Opinion on Drug Discovery. 11(3). 241–256. 29 indexed citations

12.

Hart, Thomas D., et al.. (2015). A new method to improve network topological similarity search: applied to fold recognition. Bioinformatics. 31(13). 2106–2114. 10 indexed citations

13.

Xie, Lei, et al.. (2014). Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine. PLoS Computational Biology. 10(5). e1003554–e1003554. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact